Similarly, EGF can induce PTHrP production, and treatment with EGF receptor tyrosine kinase inhibitors, erlotinib or gefitinib, significantly decreased PTHrP expression and tumor-induced osteolysis in non-small cell lung cancer cells [119,120]. The gene discussed is PTHLH; the disease is non-small cell lung carcinoma.